Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MITOCHONDRIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MITOCHONDRIA is a cell type relevant to neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 2262 entities in the SciDEX knowledge graph.
No AI portrait yet
| Cell Type | MITOCHONDRIA |
| Associated Diseases | ALS, Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis |
| Related Genes | ALZHEIMER'S DISEASE, APOPTOSIS, LC3, MITOCHONDRIAL DNA |
| Linked Hypotheses | 359 hypotheses |
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
ALZHEIMER["ALZHEIMER"] -->|"associated with"| MITOCHONDRIA["MITOCHONDRIA"]
AUTOPHAGY["AUTOPHAGY"] -->|"associated with"| MITOCHONDRIA["MITOCHONDRIA"]
end
subgraph Signaling["Signaling"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"activates"| Ischemia["Ischemia"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"activates"| Mtor["Mtor"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"activates"| Autophagy["Autophagy"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"activates"| Aging["Aging"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"regulates"| Parkinson["Parkinson"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"regulates"| Alzheimer["Alzheimer"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"activates"| Tumor["Tumor"]
MITOPHAGY["MITOPHAGY"] -->|"regulates"| MITOCHONDRIA["MITOCHONDRIA"]
SQSTM1["SQSTM1"] -->|"activates"| MITOCHONDRIA["MITOCHONDRIA"]
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"activates"| MITOCHONDRIA["MITOCHONDRIA"]
MTDNA["MTDNA"] -->|"activates"| MITOCHONDRIA["MITOCHONDRIA"]
end
subgraph Interactions["Interactions"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"interacts with"| Autophagy_1["Autophagy"]
end
style MITOCHONDRIA fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEUROINFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Ischemia fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy_1 fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Aging fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Parkinson fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Tumor fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOPHAGY fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style SQSTM1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOCHONDRIAL_DNA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MTDNA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| ULK1 | activates | gene | 1.00 |
| Mitophagy | regulates | pathway | 1.00 |
| Infection | activates | disease | 1.00 |
| Autophagy | interacts_with | pathway | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| MTOR | activates | gene | 1.00 |
| Neurodegeneration | causes | disease | 1.00 |
| Als | expressed_in | disease | 1.00 |
| Mitochondrial Function | therapeutic_target | pathway | 1.00 |
| Als | causes | disease | 1.00 |
| Parkinson | protects_against | disease | 1.00 |
| Cancer | regulates | disease | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| ATP | activates | gene | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Cardiac | activates | disease | 1.00 |
| Differentiation | regulates | pathway | 1.00 |
| PARKIN | inhibits | gene | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Breast Cancer | activates | disease | 1.00 |
| Apoptosis | inhibits | pathway | 1.00 |
| Neuroinflammation | associated_with | disease | 1.00 |
| PARKIN | regulates | gene | 1.00 |
| DNA | associated_with | gene | 1.00 |
| Parkinson | regulates | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Mitochondrial Function | associated_with | pathway | 1.00 |
| Als | associated_with | disease | 1.00 |
| Alzheimer | regulates | disease | 1.00 |
| Mitophagy | inhibits | pathway | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| Diabetes | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Mitochondrial Function | activates | pathway | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| Mitophagy | activates | pathway | 1.00 |
| PARKIN | activates | gene | 1.00 |
| Obesity | activates | disease | 1.00 |
| Oxidative Stress | inhibits | pathway | 1.00 |
| Mapk | activates | pathway | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Autophagy | associated_with | pathway | 1.00 |
| Oxidative Stress | associated_with | pathway | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| OXIDATIVE STRESS | associated_with | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| MTDNA | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| MITOCHONDRIAL DNA | associated_with | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| MITOPHAGY | associated_with | gene | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| AUTOPHAGY | interacts_with | gene | 1.00 |
| UBIQUITIN | regulates | gene | 1.00 |
| NEURODEGENERATION | causes | gene | 1.00 |
| PINK1 | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| MITOPHAGY | regulates | pathway | 1.00 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 1.00 |
| OXIDATIVE STRESS | inhibits | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| PARKINSON | associated_with | gene | 1.00 |
| CANCER | targets | gene | 1.00 |
| INFLAMMATION | associated_with | gene | 1.00 |
| AMPK | activates | gene | 1.00 |
| NLRP3 | activates | gene | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| CANCER | regulates | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| ALZHEIMER | regulates | gene | 1.00 |
| MTDNA | activates | gene | 1.00 |
| APOPTOSIS | inhibits | gene | 1.00 |
| SQSTM1 | activates | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 1.00 |
| MITOPHAGY | inhibits | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| MITOPHAGY | activates | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| UBIQUITIN | activates | gene | 1.00 |
| PARKIN | activates | gene | 1.00 |
| MITOCHONDRIAL DNA | activates | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 1.00 |
| LC3 | activates | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| ROS | inhibits | gene | 1.00 |
| PARKINSON'S DISEASE | activates | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| PTEN | activates | gene | 1.00 |
| AGING | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.914
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.639
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Irisin effects on osteogenic differentiation in mesenchymal stem cells | exploratory | bone fracture | 0.900 | 0.00 | mouse bone mesenchymal stem ce | proposed | N/A |
| iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD | exploratory | Parkinson's disease | 0.900 | 0.00 | iPSC-derived dopaminergic neur | proposed | N/A |
| Autophagy receptor identification for stress granule elimination | exploratory | neurodegenerative diseases | 0.900 | 0.00 | cultured cells under arsenite | proposed | N/A |
| PGC-1α knockout analysis of PV+ interneuron maturation | validation | neurodevelopmental disorders | 0.850 | 0.00 | knockout mice | proposed | N/A |
| PV+ interneuron subtype diversification analysis | exploratory | neurodevelopmental disorders | 0.750 | 0.00 | mouse cortical PV+ interneuron | proposed | N/A |
| Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| Metabolic Pathway-Targeted Therapy in ALS | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Animal Model Comparison for Neurodegenerative Disease Therapeutics | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec | validation | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $160,000 |
| GLP-1 Agonist Neuroprotection Mechanism in PD | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Proposed experiment from debate on Senolytics targeting p16/p21+ senes | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $180,000 |
| Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
| cGAS-STING Pathway Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| Mixed Pathology Effects on Parkinson's Disease Progression and Treatme | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| NLRP3 Inflammasome Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655] | Jorstad NL, Close J, Johansen N, Yanny A | Science | 2023 | 186 |
| TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] | Yu CH, Davidson S, Harapas CR, Hilton JB | Cell | 2020 | 2 |
| Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] | Han QQ, Shen SY, Liang LF, Chen XR, Yu J | Brain Behav Immun | 2024 | 1 |
| Increased mitophagy protects cochlear hair cells from aminoglycoside-induced dam [PMID:35471096] | Zhang Y, Fang Q, Wang H, Qi J, Sun S, Li | Autophagy | 2023 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains. [PMID:32722981] | Wu X, Zheng Y, Liu M, Li Y, Ma S, Tang W | Autophagy | 2021 | 1 |
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] | Wang Y, An H, Liu T, Qin C, Sesaki H, Gu | Cell Rep | 2019 | 1 |
| AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] | Song X, Zhu S, Chen P, Hou W, Wen Q, Liu | Curr Biol | 2018 | 1 |
| Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuro [PMID:26121488] | Hang L, Thundyil J, Lim KL | Ann N Y Acad Sci | 2015 | 1 |
| SIRT5 regulation of ammonia-induced autophagy and mitophagy. [PMID:25700560] | Polletta L, Vernucci E, Carnevale I, Arc | Autophagy | 2015 | 1 |
| Past, present and future perspectives on the science of aging. [PMID:41566049] | Fabrisia Ambrosio; Maxim N Artyomov; Ste | Nature aging | 2026 | 0 |
| PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via t [PMID:41612594] | Chen K, Zhang Y, Ruan H, Wei Z, Wang K, | Autophagy | 2026 | 0 |
| AMPKα1 Deficiency in Macrophages Impairs Tendon Regeneration and Tendon Stem Cel [PMID:41694579] | Zhu L, Wang Y, Shi X, Yu M, Cai X, Chen | International journal of biolo | 2026 | 0 |
| Single-cell transcriptome analysis reveals a cellular immune response in common [PMID:41692207] | Shi X, Ji G, Liu D, Zhao T, Tian S, Li S | International journal of biolo | 2026 | 0 |
| Farrerol ameliorates hepatic insulin resistance via AMPKα1/mTOR/SREBP-1 pathway: [PMID:41702183] | Li Y, Feng X, Zheng L | Tissue & cell | 2026 | 0 |
| ROS-responsive nanogels for brain targeted delivery of icariin in the treatment [PMID:41197818] | ["Li X", "Huang J", "Zhou Y", "Chen X", | International journal of pharm | 2026 | 0 |
| Single-Cell RNA Sequencing and Network Pharmacology Reveal the Potential Role of [PMID:41610872] | ["Niu J", "Wang L", "Qi J", "Lu G"] | The journal of gene medicine | 2026 | 0 |
| Targeted nanovesicular delivery of dexmedetomidine modulates microglial lysosoma [PMID:41778730] | Zhang Y, Jiang H, Zhang F, Liao J | Neural regeneration research | 2026 | 0 |
| Integrated Profiling of DEHP-Induced Hippocampal Neurotoxicity in Adult Female R [PMID:41600627] | Bai J, Li J, Tang L, Sun W, Gao F, Zhang | Toxics | 2026 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
closed · Rounds: 4 · Score: 0.95 · 2026-04-01
Hypotheses and analyses mentioning MITOCHONDRIA in their description or question text
Score: 0.778 · neurodegeneration · 2026-04-16
## Mechanistic Overview SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resiliency Against Microbiome-Induced Neu
Score: 0.742 · neurodegeneration · 2026-04-02
## Mechanistic Overview Senescent Cell Mitochondrial DNA Release starts from the claim that modulating CGAS/STING1/DNASE
Score: 0.742 · neurodegeneration · 2026-04-02
## Mechanistic Overview Near-infrared light therapy stimulates COX4-dependent mitochondrial motility enhancement starts
Score: 0.740 · neurodegeneration · 2026-04-25
Insufficient KEAP1-NRF2-ARE signaling reduces glutathione synthesis, quinone detoxification, and peroxide buffering, lea
Score: 0.738 · Alzheimer's Disease · 2026-04-02
## Mechanistic Overview SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy Dysfunction start
Score: 0.725 · neurodegeneration · 2026-04-02
## Mechanistic Overview TFAM overexpression creates mitochondrial donor-recipient gradients for directed organelle traff
Score: 0.701 · neurodegeneration · 2026-04-02
## Mechanistic Overview Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration starts from the claim that modulating SI
Score: 0.695 · neurodegeneration · 2026-04-02
## Mechanistic Overview Mitochondrial Transfer Pathway Enhancement starts from the claim that modulating MIRO1 within th
Score: 0.686 · neurodegeneration · 2026-04-02
## Mechanistic Overview CX43 hemichannel engineering enables size-selective mitochondrial transfer starts from the claim
Score: 0.681 · neurodegeneration · 2026-04-04
## Mechanistic Overview CRISPR-Mediated Mitochondrial Genome Editing for Complex I Dysfunction starts from the claim tha
Score: 0.674 · neurodegeneration · 2026-04-02
## Mechanistic Overview RAB27A-dependent extracellular vesicle engineering for mitochondrial cargo delivery starts from
Score: 0.668 · neurodegeneration · 2026-04-02
## Mechanistic Overview Mitochondrial-Lysosomal Contact Site Engineering starts from the claim that modulating RAB7A wit
Score: 0.666 · neurodegeneration · 2026-04-02
## Mechanistic Overview GAP43-mediated tunneling nanotube stabilization enhances neuroprotective mitochondrial transfer
Score: 0.656 · neurodegeneration · 2026-04-02
## Mechanistic Overview Mitochondrial RNA Granule Rescue Pathway starts from the claim that modulating SYNCRIP within th
Score: 0.656 · neurodegeneration · 2026-04-21
## Mechanistic Overview Cyclophilin D (CypD) Displacement by Mitochondrial TDP-43 starts from the claim that modulating